• Boston Scientific (Natick, Massachusetts) reported FDA approval for three products in its cardiac rhythm management business. They include the Confident implantable cardioverter defibrillator (ICD), which helps protect patients at risk of sudden cardiac death; the Livian cardiac resynchronization therapy defibrillator (CRT-D), which provides cardiac resynchronization and defibrillation therapies in one device; and an upgraded Latitude patient management system, with enhanced remote monitoring capabilities. The Confident ICD features an enhanced AV search hysteresis feature designed to reduce unnecessary right ventricular pacing. The Livian CRT-D lets physicians provide patients with individualized therapy using the SmartDelay and Bi-V trigger features. The upgraded Latitude includes new patient alerts.